Samarth Kulkarni
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 24SEC | CRSPCRISPR Therapeutics AG | Sell | 10,020255,501 held (−4%) | $46.78 | $469K | +14.1% |
| Mar 17SEC | CRSPCRISPR Therapeutics AG | Sell | 10,349245,834 held (−4%) | $48.26 | $499K | +10.6% |
| Mar 12SEC | CRSPCRISPR Therapeutics AG | Sell | 9,798235,558 held (−4%) | $52.80 | $517K | +1.1% |
| Feb 20SEC | CRSPCRISPR Therapeutics AG | Sell | 6,967226,106 held (−3%) | $52.58 | $366K | +1.5% |
| Jan 22SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 21,433202,768 held (−10%) | $51.61 | $1.1M | +3.4% |
| Jan 22SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 8,567194,201 held (−4%) | $52.10 | $446K | +2.5% |
| Jan 22SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 60,000134,201 held (−31%) | $60.23 | $3.6M | -11.4% |
| Oct 20SEC | CRSPCRISPR Therapeutics AG | Sell | 50,895254,201 held (−17%) | $67.91 | $3.5M | -21.4% |
| Oct 15SEC | CRSPCRISPR Therapeutics AG | Sell | 4,242205,096 held (−2%) | $66.60 | $283K | -19.8% |
- Sell
CEO Samarth Kulkarni sold $1.1M of CRSP at $51.61 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Samarth Kulkarni sold $446K of CRSP at $52.10 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Samarth Kulkarni sold $3.6M of CRSP at $60.23 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.